Inventor · disambiguated record
Nicoletta Almirante
Also filed as: ALMIRANTE NICOLETTA
24 granted patents·16 pending applications·32 citations·filing 1993–2024
92Inventor score
Top patents by PatentIndex Score
40 records- 0182US10988438B2Process for the preparation of a nitric oxide donating prostaglandin analogueNICOX SA·Filed 2019·Granted Apr 27, 2021·1 cites·16 claims
- 0281US8003811B2Nitric oxide donor compoundsNICOX SA·Filed 2009·Granted Aug 23, 2011·10 cites·12 claims
- 0381US7858665B2Drugs for chronic painNICOX SA·Filed 2009·Granted Dec 28, 2010·3 cites·7 claims
- 0475US11980618B2Nitric oxide releasing phosphodiesterase type 5 inhibitorNICOX SA·Filed 2019·Granted May 14, 2024·1 cites·14 claims
- 0575US7880014B2Angiotensin II receptor antagonistsMERCK SHARP & DOHME·Filed 2007·Granted Feb 1, 2011·2 cites·7 claims
- 0673US7723529B2Process for preparing nitrooxy esters, nitrooxy thioesters nitrooxy carbonates and nitrooxy thiocarbinates, intermediates useful in said process and preparation thereofNICOX SA·Filed 2005·Granted May 25, 2010·2 cites·9 claims
- 0772US2024018096A1Industrial process for the preparation of hexanoic acid, 6-(nitrooxy)-, (1s,2e)-3-[(1r,2r,3s,5r)-2-[(2z)-7-(ethylamino)-7-oxo-2-hepten-1-yl]-3,5-dihydroxycyclopentyl]-1-(2-phenylethyl)-2-propen-1-yl ester and high pure productNICOX SA·Filed 2023·Application pending·0 cites
- 0871US2024245684A1Nitric oxide releasing phosphodiesterase type 5 inhibitorNICOX SA·Filed 2024·Application pending·0 cites
- 0970US8119806B2Cicletanine derivativesALI AMJAD·Filed 2009·Granted Feb 21, 2012·1 cites·12 claims
- 1070US2025320182A1Industrial process for the preparation of hexanoic acid, 6-(nitrooxy)-, (1s,2e)-3-[(1r,2r,3s,5r)-2-[(2z)-7-(ethylamino)-7-oxo-2-hepten-1-yl]-3,5-dihydroxycyclopentyl]-1-(2-phenylethyl)-2-propen-1-yl ester and high pure productNICOX SA·Filed 2023·Application pending·0 cites
- 1167US7217733B2ACE inhibitor derivativesNICOX SA·Filed 2004·Granted May 15, 2007·3 cites·12 claims
- 1263US8252825B2Angiotensin II receptor antagonistsALI AMJAD·Filed 2008·Granted Aug 28, 2012·0 cites·3 claims
- 1362US8207208B2Angiotensin II receptor antagonistsALI AMJAD·Filed 2009·Granted Jun 26, 2012·0 cites·10 claims
- 1459US9895335B2Ophthalmic compositions containing a nitric oxide donorNICOX SCIENCE IRELAND·Filed 2014·Granted Feb 20, 2018·0 cites·20 claims
- 1559US2025017928A1Ophthalmic pharmaceutical compositions containing a nitric oxide-releasing phosphodiesterase 5 inhibitor and method for the preparation thereofNICOX SA·Filed 2022·Application pending·0 cites
- 1658US9266820B2Nitric oxide donor compoundsNICOX SA·Filed 2014·Granted Feb 23, 2016·0 cites·9 claims
- 1755US2023414621A1No-pde5 inhibitor for use in treating dry age-related macular degeneration, geographic atrophy and glaucoma-associated neurodegenerationNICOX SA·Filed 2021·Application pending·0 cites
- 1853US8367711B2Angiotensin II receptor antagonistsMERCK SHARP & DOHME·Filed 2012·Granted Feb 5, 2013·0 cites·11 claims
- 1953US2022274924A1Process for the preparation of a nitric oxide donating prostaglandin analogueNICOX SA·Filed 2020·Application pending·0 cites
- 2053US2010099729A1Nitric oxide donor compoundsNICOX SA·Filed 2008·Application pending·0 cites
- 2150US9446015B2Quinone based nitric oxide donating compounds for ophthalmic useNICOX SCIENCE IRELAND·Filed 2013·Granted Sep 20, 2016·0 cites·19 claims
- 2250US2010311800A1Angiotensin ii receptor antagonistsALMIRANTE NICOLETTA·Filed 2009·Application pending·0 cites
- 2349US2011077279A1Angiotensin ii receptor antagonistsALMIRANTE NICOLETTA·Filed 2009·Application pending·0 cites
- 2448US2023069076A1Compositions for the treatment of glaucoma and ocular hypertensionNICOX SA·Filed 2021·Application pending·0 cites
- 2548US2011052674A1Angiotensin ii receptor blocker derivativesMERCK SHARP & DOHME·Filed 2009·Application pending·0 cites
- 2647US2024158345A1Process for the preparation of a nitric oxide donating prostaglandin analogueNICOX SA·Filed 2021·Application pending·0 cites
- 2747US2006276523A1Nitoroxy derivatives of losartan, valsatan, candesartan, telmisartan, eprosartan and olmesartan as angiotensin-II receptor blockers for the treatment of cardiovascular diseasesALMIRANTE NICOLETTA·Filed 2004·Application pending·0 cites
- 2846US7169805B2Captopril derivativesNICOX SA·Filed 2004·Granted Jan 30, 2007·0 cites·24 claims
- 2946US2010166839A1Non peptidic renin inhibitors nitroderivativesNICOX SA·Filed 2007·Application pending·0 cites
- 3046US2009263472A1Endothelin receptor antagonist derivativesNICOX SA·Filed 2007·Application pending·0 cites
- 3143US10280138B2Nitric oxide donating derivatives of fluprostenolNICOX SA·Filed 2016·Granted May 7, 2019·0 cites·18 claims
- 3242US5567694A17-Aryl and 17-heterocyclyl-5β,14β-androstane derivatives active on the cardiovascular system, processes for their preparation and pharmaceutical compositions containing sameSIGMA TAU IND FARMACEUTI·Filed 1993·Granted Oct 22, 1996·5 cites·8 claims
- 3341US10610509B2Combinations of prostaglandins and nitric oxide donorsNICOX SA·Filed 2015·Granted Apr 7, 2020·0 cites·6 claims
- 3441US9598349B2Quinone based nitric oxide donating compounds for ophthalmic useNICOX SCIENCE IRELAND·Filed 2014·Granted Mar 21, 2017·0 cites·25 claims
- 3541US7642289B2Drugs for chronic painNICOX SA·Filed 2003·Granted Jan 5, 2010·0 cites·8 claims
- 3637US2008274171A1Renin Inhibitors NitroderivativesALMIRANTE NICOLETTA·Filed 2006·Application pending·0 cites
- 3735US10047047B2Nitric oxide donating derivatives of latanoprost free acidNICOX SA·Filed 2016·Granted Aug 14, 2018·0 cites·19 claims
- 3833US5324719ATherapeutical method for the treatment of hypertensionSIGMA TAU IND FARMACEUTI·Filed 1993·Granted Jun 28, 1994·4 cites·2 claims
- 3930US5705531A1,5-disubstituted 7A-methylperhydroinden-3A-ol derivatives, useful in treating cardiovascular disorders, processes for their preparation and pharmaceutical compositions containing the sameSIGMA TAU IND FARMACEUTI·Filed 1995·Granted Jan 6, 1998·0 cites·8 claims
- 4028US10093696B2Nitric oxide donating carnosine compoundsNICOX SCIENCE IRELAND·Filed 2015·Granted Oct 9, 2018·0 cites·18 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →